Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Headlines

ICON to acquire PRA Health Sciences in $12b deal

The deal consolidates two significant players in the contract research organization arena, in a deal reportedly worth approximately $12b USD.

Community building empowers rare-disease patients: Xperiome

An executive from the rare disease technology solutions company discusses how forcing connections with patients can boost research into such conditions.

Patient-centric approach key to rare disease research: Centogene

A leader from the genetics diagnostic solutions company explains how putting the patient first can make the difference in orphan drug development.

COVID-19 elevates appreciation, use of RBQM: CluePoints

A leader from the risk-based quality management solutions provider will discuss the growing interest in the technology, during this year’s SCOPE event.

SCOPE 2021 to take on tough clinical trial challenges

The annual event, moved to the virtual realm thanks to COVID-19, offers content on remote monitoring, drug development technology and other key topics.